ARMI | BioFabUSA will proudly host and participate in the Breakthrough T1D Walk 2025, taking place on October 4, 2025, in Manchester, NH. This important community event raises awareness and critical funding for Type 1 Diabetes (T1D) research and support programs.
The Breakthrough T1D Walk is more than just a fundraising event—it is a celebration of resilience, advocacy, and hope for individuals and families affected by Type 1 Diabetes. As a host site and active participant, ARMI is honored to stand alongside the T1D community in support of medical research, education, and empowerment.
At the 2025 Walk, ARMI will:
As an organization committed to advancing biomedical innovation, ARMI sees the Walk as a powerful opportunity to connect science with community impact. Our participation also reflects our broader mission of promoting health equity and fostering partnerships that accelerate breakthroughs in regenerative medicine.
We invite you to join the ARMI team, form your own walking group, or support a participating team at this year’s event.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
